LUCY AMIEVA: Open Payments
NPI 1972176667 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 35 payments from 16 companies in 2025. Trend: 2023 $1,036 · 2024 $825 · 2025 $882
Food & beverage: $862Education: $20
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 6 | $183 |
| Alnylam Pharmaceuticals Inc. | 4 | $147 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| Esperion Therapeutics, Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| HARMONY BIOSCIENCES LLC | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| 3B Medical, Inc. | 1 | $32 |
Products named: XYWAV, LEQVIO, ONPATTRO, NEXLETOL, Kerendia, SHINGRIX, WAKIX, AMVUTTRA.
Industry payments across TX — which companies pay providers there.
